Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.

doi:10.1001/jama.2011.351

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.

Odile O Launay, Diane D van der Vliet, Arielle R AR Rosenberg, Marie-Louise ML Michel, Lionel L Piroth, David D Rey, Nathalie N Colin de Verdière, Laurence L Slama, Karine K Martin, Olivier O Lortholary, Fabrice F Carrat, and

JAMA 305(14):1432-40 (2011) PMID 21486976

Alternative schedules more immunogenic than the standard hepatitis B vaccine regimen are needed in patients with human immunodeficiency virus 1 (HIV-1) infection.

DOI: 10.1001/jama.2011.351
Version: za2963e q8za3 q8zbc q8zc2 q8zdf q8zea q8zfb q8zga

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.

Similar articles you may find interesting…